Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis

In 2020, almost half a million individuals developed rifampicin-resistant tuberculosis (RR-TB). We estimated the global burden of RR-TB over the lifetime of affected individuals. We synthesized data on incidence, case detection, and treatment outcomes in 192 countries (99.99% of global tuberculosis)...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzies, Nicolas A., Allwood, Brian W., Dean, Anna S., Dodd, Pete J., Houben, Rein M. G. J., James, Lyndon P., Knight, Gwenan M., Meghji, Jamilah, Nguyen, Linh N., Rachow, Andrea, Schumacher, Samuel G., Mirzayev, Fuad, Cohen, Ted
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550952/
https://www.ncbi.nlm.nih.gov/pubmed/37794037
http://dx.doi.org/10.1038/s41467-023-41937-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550952/
https://www.ncbi.nlm.nih.gov/pubmed/37794037
http://dx.doi.org/10.1038/s41467-023-41937-9

Ejemplares similares